Japanese babies with eye disease monitored on eylea in new safety study
NCT ID NCT05705258
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This observational study tracks 75 Japanese babies with retinopathy of prematurity (ROP) who are already prescribed Eylea. Researchers will collect safety and effectiveness data from routine medical visits over 6 months. The goal is to see how well Eylea works and what side effects occur in real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINOPATHY OF PREMATURITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many locations
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.